PLAUR and prostate carcinoma: In fact, we have shown that inhibition of uPAR interactions with integrins and FPRs impairs migration toward serum of PC3 prostate carcinoma cells and of uPAR-transfected HEK-293 (uPAR-293) cells, although latter cells are perfectly able to migrate when lacking uPAR expression.